Emerging Neurobiology of Antidepressant Treatments
Springer International Publishing (Verlag)
978-3-031-66355-0 (ISBN)
This volume is unique in bringing the exciting range of antidepressant treatment developments together with a focus on their neurobiological mechanisms and how these interact with the known pathophysiology of depression. Current evidence for treatment efficacy is reviewed together with a discussion of where in the management pathway of this common condition, these new approaches might take their place.
SSRIs A pharmacological cul-de-sac.- Neurobiology of SSRI withdrawal.- Pramipexole in the treatment of depression.- Opioid mechanisms in the treatment of depression.- Neuropsychological effects of antidepressants-translational studies.- KETAMINE FOR MAJOR DEPRESSIVE DISORDER.- Psilocybin and other classic psychedelics in depression.- Gut-brain axis and antidepressant treatment.- Anti-inflammatory drugs in the treatment of depression.- Mechanisms of TMS in Depression.- Mechanism of action of ECT in depression.- Vagal nerve stimulation in the treatment of depression.
| Erscheinungsdatum | 26.07.2024 |
|---|---|
| Reihe/Serie | Current Topics in Behavioral Neurosciences |
| Zusatzinfo | X, 311 p. 100 illus., 30 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
| Medizin / Pharmazie ► Studium | |
| Naturwissenschaften ► Biologie ► Humanbiologie | |
| Schlagworte | antidepressants • brexanolone • Depression • ECT • Ketamine • Opiates • orexins • pramipexole • Probiotics • Psilocybin • SSRIs • TMS • VNS |
| ISBN-10 | 3-031-66355-1 / 3031663551 |
| ISBN-13 | 978-3-031-66355-0 / 9783031663550 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
